β¨ Medicines Act Notices
2870 NEW ZEALAND GAZETTE, No. 97 17 AUGUST 2006
Medicines Act 1981
Consent to the Distribution of New Related Products
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:
Schedule
Product: Head & Shoulders Anti-Dandruff Conditioner β Natural Shine
Active Ingredient: Pyrithione zinc 0.5%w/v
Dosage Form: Scalp lotion
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Procter & Gamble Manufacturing (Thailand) Limited, Wellgrow Industrial Estate, Bangkpakong, Chacheonsao, Thailand
Product: Head & Shoulders Anti-Dandruff Shampoo β Natural Shine
Active Ingredient: Pyrithione zinc 1%w/v
Dosage Form: Shampoo
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Procter & Gamble Manufacturing (Thailand) Limited, Wellgrow Industrial Estate, Bangkpakong, Chacheonsao, Thailand
Dated this 10th day of August 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go5558
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Avelox IV 400
Active Ingredient: Moxifloxacin hydrochloride 436.8mg equivalent to 400mg moxifloxacin
Dosage Form: Solution for infusion
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Germany
Product: Avelox
Active Ingredient: Moxifloxacin hydrochloride 436.8mg equivalent to 400mg moxifloxacin
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Germany
Product: Modavigil
Active Ingredient: Modafinil 100mg
Dosage Form: Tablet
New Zealand Sponsor: CSL New Zealand Limited
Manufacturers: Laboratoires Macors, Zone Industrielle de la Plaine des Isles, Auxerre, France
Laboratoires Opodex Industrie, Saint-Denis, Villeneuve la Garenne, (Hauts-de-Seine), France
Dated this 10th day of August 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go5559
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: OxyNorm
Active Ingredient: Oxycodone hydrochloride 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Mundipharma New Zealand Limited
Manufacturer: BCM Limited, Nottingham, United Kingdom
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 97
Gazette.govt.nz —
NZ Gazette 2006, No 97
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Related Products
π₯ Health & Social Welfare10 August 2006
Medicines, Distribution, Head & Shoulders, Pyrithione zinc
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to Distribution of Changed Medicines
π₯ Health & Social Welfare10 August 2006
Medicines, Distribution, Avelox, Modavigil, Moxifloxacin, Modafinil
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare10 August 2006
Medicines, Distribution, OxyNorm, Oxycodone
- DON MATHESON, Deputy Director-General, Public Health